APYX Logo

Apyx Medical Corp (APYX) Stock Forecast & Price Prediction

Live APYX Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NASDAQ | Healthcare | Medical Devices

$1.48

+0.04 (3.06%)

12 Month Price Forecast For APYX

$1.48
Current Price
$55.71M
Market Cap
4 Ratings
Buy 1
Hold 3
Sell 0
Wall St Analyst Ratings

Distance to APYX Price Forecasts

+170.3%
To High Target of $4.00
+102.7%
To Median Target of $3.00
+35.1%
To Low Target of $2.00

APYX Price Momentum

-2.6%
1 Week Change
-14.0%
1 Month Change
-44.8%
1 Year Change
-6.3%
Year-to-Date Change
-47.1%
From 52W High of $2.80
+53.1%
From 52W Low of $0.97

๐Ÿค” Considering Apyx Medical (APYX)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 6, 2025 11:00 AM UTC

APYX Analyst Ratings & Price Targets

Based on our analysis of 7 Wall Street analysts, APYX has a consensus that is neutral. The median price target is $3.00, with forecasts ranging from $2.00 to $4.00. Currently, there are 1 Buy ratings, 3 Hold ratings, and 0 Sell ratings.

With APYX currently trading at $1.48, the median price forecast suggests a 102.7% upside. The most optimistic forecast comes from at , projecting a 170.3% upside, while at provides the most conservative target, suggesting a 35.1% upside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

APYX Analyst Consensus

1
Buy
3
Hold
0
Sell

APYX Price Target Range

Low
$2.00
Average
$3.00
High
$4.00
Current: $1.48

Latest APYX Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for APYX.

Date Firm Analyst Rating Change Price Target
Oct 17, 2024 BTIG Sam Eiber Neutral Initiates $0.00
Sep 16, 2024 JMP Securities David Turkaly Market Perform Reiterates $0.00
Nov 10, 2023 Stephens & Co. George Sellers Overweight Maintains $5.00
Aug 11, 2023 Piper Sandler Matt O'Brien Overweight Maintains $4.50
Jul 14, 2023 Stephens & Co. George Sellers Overweight Initiates $8.00
Jun 15, 2023 Lake Street Frank Takkinen Buy Maintains $9.00
May 24, 2023 JMP Securities David Turkaly Market Perform Reiterates $0.00
May 12, 2023 Lake Street Frank Takkinen Buy Maintains $6.00
Dec 8, 2022 Lake Street Frank Takkinen Buy Assumes $5.00
Aug 12, 2022 Piper Sandler Matt O'Brien Overweight Maintains $12.00
Jul 19, 2022 Lake Street Kyle Bauser Buy Maintains $17.00
May 20, 2022 Lake Street Buy Initiates $0.00
Aug 13, 2021 JMP Securities David Turkaly Market Outperform Maintains $14.00
May 12, 2020 JMP Securities Market Outperform Maintains $5.00
Nov 12, 2019 Piper Sandler Overweight Maintains $10.00
Nov 12, 2019 Piper Jaffray Overweight Maintains $0.00
Apr 2, 2019 JMP Securities Market Outperform Maintains $8.00

Stocks Similar to Apyx Medical Corp

The following stocks are similar to Apyx Medical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Apyx Medical Corp (APYX) Financial Data

Apyx Medical Corp has a market capitalization of $55.71M with a P/E ratio of -2.7x. The company generates $49.03M in trailing twelve-month revenue with a -57.9% profit margin.

Revenue growth is -10.5% quarter-over-quarter, while maintaining an operating margin of -45.7% and return on equity of -110.2%.

Valuation Metrics

Market Cap $55.71M
Enterprise Value $48.47M
P/E Ratio -2.7x
PEG Ratio -2.8x
Price/Sales 1.1x

Growth & Margins

Revenue Growth (YoY) -10.5%
Gross Margin +60.5%
Operating Margin -45.7%
Net Margin -57.9%
EPS Growth -4.1%

Financial Health

Cash/Price Ratio +63.7%
Current Ratio 5.3x
Debt/Equity 259.3x
ROE -110.2%
ROA -21.8%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Apyx Medical Corp logo

Apyx Medical Corp (APYX) Company Overview

About Apyx Medical Corp

What They Do

Develops medical devices using energy technology.

Business Model

Apyx Medical Corporation generates revenue by designing, developing, and manufacturing advanced energy medical devices, particularly through its Helium Plasma Technology. The company operates in two segments: Advanced Energy, which includes its Helium Plasma Generator for surgical procedures, and Original Equipment Manufacturing (OEM), where it produces devices and accessories for other brands.

Additional Information

The company's products are marketed under the Renuvion name in cosmetic surgery and the J-Plasma name in hospital surgical markets. Apyx Medical was formerly known as Bovie Medical Corporation and rebranded in January 2019. It has a long history since its incorporation in 1982 and is based in Clearwater, Florida.

Company Information

Sector

Healthcare

Industry

Medical Devices

Employees

252

CEO

Mr. Charles D. Goodwin II

Country

United States

IPO Year

2019

Apyx Medical Corp (APYX) Latest News & Analysis

APYX stock latest news image
Quick Summary

A new all-in-one platform for body contouring is being introduced for surgical suites, aiming to enhance efficiency and innovation in the field.

Why It Matters

The introduction of an all-in-one platform for body contouring could enhance operational efficiency and attract more clients, potentially boosting revenue for related companies.

Source: GlobeNewsWire
Market Sentiment: Neutral
APYX stock latest news image
Quick Summary

Apyx Medical Corporation (NASDAQ: APYX) announced that CEO Charles Goodwin and CFO Matt Hill will attend an upcoming conference.

Why It Matters

Leadership presence at conferences can signal confidence and strategic direction, potentially influencing investor sentiment and stock performance for Apyx Medical.

Source: GlobeNewsWire
Market Sentiment: Neutral
APYX stock latest news image
Quick Summary

Apyx Medical Corporation (NASDAQ:APYX) held its Q3 2024 earnings call on November 8, 2024, with key executives and analysts participating.

Why It Matters

Apyx Medical's Q3 2024 earnings call signals upcoming financial insights and strategic direction, which can influence stock performance and investor sentiment.

Source: Seeking Alpha
Market Sentiment: Neutral
APYX stock latest news image
Quick Summary

Apyx Medical Corporation (NASDAQ: APYX) reported Q3 results for 2024 and updated its financial outlook for 2024 and introduced expectations for 2025.

Why It Matters

Apyx Medical's Q3 financial results and updated forecasts signal growth potential, influencing investor sentiment and stock performance in the medical technology sector.

Source: GlobeNewsWire
Market Sentiment: Neutral
APYX stock latest news image
Quick Summary

Apyx Medical (APYX) reported a quarterly loss of $0.14 per share, beating the Zacks Consensus Estimate of $0.15 but worsening from a loss of $0.13 per share a year ago.

Why It Matters

Apyx Medical's smaller-than-expected loss may signal improving financial performance, potentially boosting investor sentiment and stock price. Year-over-year loss increase could raise concerns.

Source: Zacks Investment Research
Market Sentiment: Negative
APYX stock latest news image
Quick Summary

Apyx Medical Corporation (NASDAQ:APYX) announced a direct offering of 3 million shares at $1.18 each and pre-funded warrants for 2.93 million shares, raising approximately $7 million.

Why It Matters

Apyx Medical's $7M capital raise through a direct offering may enhance liquidity and fund growth initiatives, impacting stock performance and investor sentiment.

Source: GlobeNewsWire
Market Sentiment: Neutral

Frequently Asked Questions About APYX Stock

What is Apyx Medical Corp's (APYX) stock forecast for 2025?

Based on our analysis of 7 Wall Street analysts, Apyx Medical Corp (APYX) has a median price target of $3.00. The highest price target is $4.00 and the lowest is $2.00.

Is APYX stock a good investment in 2025?

According to current analyst ratings, APYX has 1 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.48. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for APYX stock?

Wall Street analysts predict APYX stock could reach $3.00 in the next 12 months. This represents a 102.7% increase from the current price of $1.48. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Apyx Medical Corp's business model?

Apyx Medical Corporation generates revenue by designing, developing, and manufacturing advanced energy medical devices, particularly through its Helium Plasma Technology. The company operates in two segments: Advanced Energy, which includes its Helium Plasma Generator for surgical procedures, and Original Equipment Manufacturing (OEM), where it produces devices and accessories for other brands.

What is the highest forecasted price for APYX Apyx Medical Corp?

The highest price target for APYX is $4.00 from at , which represents a 170.3% increase from the current price of $1.48.

What is the lowest forecasted price for APYX Apyx Medical Corp?

The lowest price target for APYX is $2.00 from at , which represents a 35.1% increase from the current price of $1.48.

What is the overall APYX consensus from analysts for Apyx Medical Corp?

The overall analyst consensus for APYX is neutral. Out of 7 Wall Street analysts, 1 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $3.00.

How accurate are APYX stock price projections?

Stock price projections, including those for Apyx Medical Corp, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.